Nazione: Australia
Lingua: inglese
Fonte: Department of Health (Therapeutic Goods Administration)
dobutamine hydrochloride, Quantity: 14.01 mg/mL (Equivalent: dobutamine, Qty 12.5 mg/mL)
Baxter Healthcare Pty Ltd
Injection, concentrated
Excipient Ingredients: sodium metabisulfite; hydrochloric acid; sodium hydroxide; water for injections
Intravenous
20 mL per ampoule, 5 ampoules per pack
(S4) Prescription Only Medicine
Adults who require short-term treatment of cardiac failure secondary to acute myocardial infarction, or cardiac surgery.???
Visual Identification: Colourless to pale yellow solution; Container Type: Ampoule; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius
Licence status A
2014-07-11
DOBUTAMINE-CLARIS _Dobutamine hydrochloride equivalent to dobutamine 250 mg/20 mL, _ _Concentrated Solution for Injection _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Dobutamine-Claris. It does not contain all the available information and does not take the place of talking with your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you being given Dobutamine-Claris against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT BEING GIVEN THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT DOBUTAMINE-CLARIS IS USED FOR This medicine contains dobutamine (as dobutamine hydrochloride) as the active ingredient. It belongs to a group of medicines called catecholamines, which are a synthetic version of a naturally occurring chemical, adrenaline. Dobutamine-Claris is used to treat patients who need short-term treatment of heart failure following a heart attack or heart surgery. It works by strengthening the pumping action of the heart, increasing the amount of blood flowing to the body and by expanding both veins and arteries, so the heart can more easily propel the blood. It helps your heart work more effectively. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed it for another reason. This medicine is only available with a doctor’s prescription. There is no evidence that it is addictive. There is not enough safety and efficacy information available to recommend the use of Dobutamine- Claris in children. BEFORE YOU ARE GIVEN IT _WHEN YOU MUST NOT BE GIVEN IT _ YOU MUST NOT BE GIVEN DOBUTAMINE-CLARIS IF YOU HAVE EVER HAD AN ALLERGIC REACTION TO: • any medicine containing dobutamine hydrochloride • any of the ingredients listed at the end of this leaflet. Some of the symptoms of an allergic reaction may include shortness of breath, wheezing or Leggi il documento completo
Product and Consumer Medicine Information Licence ------------------------- ACCESS TERMS FOR PRODUCT INFORMATION AND CONSUMER MEDICINE INFORMATION DOCUMENTS ("LICENCE") PARTIES YOU or YOUR means any legal person or entity who accesses or downloads a PI Document or CMI Document from Our website and US, WE or OUR means the COMMONWEALTH OF AUSTRALIA as represented by the THERAPEUTIC GOODS ADMINISTRATION ABN 40 939 406 804 of 136 Narrabundah Lane, Symonston ACT 2609, Australia. OPERATIVE PROVISIONS * NATURE OF AGREEMENT * 1.1 This Licence specifies the terms and conditions of Your access and use of PI Documents and CMI Documents made available to the general public by Us via Our website. * 1.2 You acknowledge and agree that accessing PI Documents or CMI Documents in accordance with this Licence is beneficial to You because it provides You with product information about therapeutic goods and is beneficial to Us because it assists Us in our portfolio responsibilities. * TERMS OF ACCESS * 2.1 We grant to You a perpetual, non-exclusive, royalty-free, world-wide, irrevocable and non-transferable licence to download, store in cache, display, print and copy a single copy or part of a single copy of a PI Document or CMI Document made available via Our website. * 2.2 If You wish to use any PI Document or CMI Document for purposes other than those specified in clause 2.1 of this Licence, You must seek the permission of the Sponsor. * 2.3 We may remove a PI Document or CMI Document from Our website at any time in Our sole discretion. * EXCLUSION OF LIABILITY * 3.1 You acknowledge and agree that You are responsible for making Your own enquiries to determine whether any PI Document or CMI Document is accurate, up to date and fit for Your purposes. * 3.2 The PI Document or CMI Document is provided to You for the purpose of disseminating health information free of charge for the benefit of the public. This Licence and any PI Document or CMI Document made available to You via Our website is not a substitute fo Leggi il documento completo